Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods

Affiliations

Clinical Trial

C G Isles et al. BMJ. 2000.

. 2000 Mar 11;320(7236):690-1.

doi: 10.1136/bmj.320.7236.690.

No abstract available

Comment in

Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculations.
Durrington PN. Durrington PN. BMJ. 2000 Jul 15;321(7254):174-5. BMJ. 2000. PMID: 10950540 No abstract available.
Comparison of methods of estimating coronary risk. Authors did not use latest version of Sheffield table.
Wallis EJ, Ramsay LE, Yikona JI, Jackson PR. Wallis EJ, et al. BMJ. 2000 Jul 15;321(7254):175-6. BMJ. 2000. PMID: 10950544 Free PMC article. No abstract available.

1. Haq IU, Jackson PR, Yeo WW, Ramsay LE. A comparison of methods for targeting CHD risk for primary prevention. Heart. 1997;77(suppl 1):36.
1. on behalf of the Scientific Committee of the National Heart Foundation of New Zealand. Dyslipidaemia Advisory Group 1996 National Heart Foundation guidelines for the assessment and management of dyslipidaemia N Z Med J 1996109224–232. - PubMed
1. Working Party of the British Cardiac Society; British Hyperlipidaemia Association and British Hypertension Society. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart. 1998;80(suppl 2):S1–29. - PMC - PubMed
1. Winyard G. Standing Medical Advisory Committee statement on the use of statins. London: Department of Health; 1997. . (EL(97)41HCD750IP, Aug 1997.)
1. Scottish Intercollegiate Guidelines Network. Edinburgh: Royal College of Physicians; 1999. Lipids and primary prevention of coronary heart disease. . (SIGN publication No 40.)